The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.

Excellence in Patient Care

Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.

Learn more

Excellence in Research

The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies. 

Learn more

Train with us

The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.

Learn more

Latest News

News
Tuesday, July 27, 2021
News
Monday, July 26, 2021
News
Wednesday, June 9, 2021
News
Wednesday, June 9, 2021
News
Monday, June 7, 2021

Upcoming Events

Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

August 6, 2021 - 8:30am
Dr. Taewoong Choi
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

August 13, 2021 - 8:30am
Dr. Colin Champ
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

August 20, 2021 - 8:30am
Dr. Louis Diehl
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

August 27, 2021 - 8:30am
Dr. Cathy Wu